Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Eike Christin Von Leitner"'
Autor:
Karsten Sydow, Christine Schmitz, Eike-Christin von Leitner, Robin von Leitner, Anna Klinke, Dorothee Atzler, Christian Krebs, Hartwig Wieboldt, Heimo Ehmke, Edzard Schwedhelm, Thomas Meinertz, Stefan Blankenberg, Rainer H Böger, Tim Magnus, Stephan Baldus, Ulrich Wenzel
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e48150 (2012)
The endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) is an independent predictor of cardiovascular and overall mortality. Moreover, elevated ADMA plasma concentrations are associated with the extent of hypertension. Howev
Externí odkaz:
https://doaj.org/article/ba66b86b380b46679af9a077171c0095
Autor:
Ingmar Schäfer, Eike-Christin von Leitner, Gerhard Schön, Daniela Koller, Heike Hansen, Tina Kolonko, Hanna Kaduszkiewicz, Karl Wegscheider, Gerd Glaeske, Hendrik van den Bussche
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15941 (2010)
OBJECTIVE: Multimorbidity is a common problem in the elderly that is significantly associated with higher mortality, increased disability and functional decline. Information about interactions of chronic diseases can help to facilitate diagnosis, ame
Externí odkaz:
https://doaj.org/article/1959d947e1ee4f469733d49844b3e831
Autor:
Frank Leypoldt, Chi-Un Choe, Mathias Gelderblom, Eike-Christin von Leitner, Dorothee Atzler, Edzard Schwedhelm, Christian Gerloff, Karsten Sydow, Rainer H Böger, Tim Magnus
Publikováno v:
PLoS ONE, Vol 4, Iss 10, p e7337 (2009)
Methylated arginines are endogenous analogues of L-arginine, the substrate for nitric oxide (NO) synthase. Asymmetric dimethylarginine (ADMA) interferes with NO formation, causing endothelial dysfunction. ADMA is a predictor of cardiovascular events
Externí odkaz:
https://doaj.org/article/49743f1ff81741f396eb1f09bcee7440
Autor:
Oliver Rinner, Tobias Treiber, Eike-Christin von Leitner, Roland Bruderer, Lukas Reiter, Karel Novy, Jakob Vowinckel, Hartmut Juhl, Jonathan Woodsmith, Thomas Corwin
Publikováno v:
Journal of Clinical Oncology. 39:e15536-e15536
e15536 Background: The rise of precision oncology therapeutics requires deep understanding of the molecular mechanisms implicated in cancer biology. Colorectal cancer (CRC) is one of the first solid tumors to be molecularly characterized by defined g
Autor:
Lukas Reiter, Jakob Vowinckel, Roland Bruderer, Karel Novy, Thomas Corwin, Claudia Escher, Oliver Rinner, Tobias Treiber, Eike-Christin von Leitner
Publikováno v:
Journal of Clinical Oncology. 38:e15672-e15672
e15672 Background: The rise of precision oncology therapeutics requires deep understanding of all molecular mechanisms involved in cancer biology. IndivuType offers the world’s first multi-omics database for individualized cancer therapy, analyzing
Autor:
Dimitrios Tsikas, Karsten Sydow, Jan T. Kielstein, Michaela Pekarova, Crystal A. Gadegbeku, Lukáš Kubala, Stefan Blankenberg, Renke Maas, Louis G. D'Alecy, Robin Schmidt-Haupt, Stephan Willems, Natalie Lund, Jessica L. Slocum, Denise Lau, Rainer H. Böger, Olaf J C Hellwinkel, Dorothee Atzler, Anna Klinke, Edzard Schwedhelm, Eike Christin Von Leitner, Thomas Meinertz, Stephan Baldus, Heimo Ehmke
Publikováno v:
Circulation. 124:2735-2745
Background— The nitric oxide synthase inhibitor asymmetrical dimethylarginine (ADMA) and the leukocyte-derived hemoprotein myeloperoxidase (MPO) are associated with cardiovascular diseases. Activation of monocytes and polymorphonuclear neutrophils
Autor:
Dorothee Atzler, Christine Schmitz, Johannes Jacobi, Rainer H. Böger, Renke Maas, Eike Christin Von Leitner, Edzard Schwedhelm, Thomas Meinertz, Thomas Münzel, Stephan Baldus, John P. Cooke, Karsten Sydow
Publikováno v:
Pharmacological Research. 60:494-502
Purpose of the research Overexpression of the human dimethylarginine dimethylaminohydrolase type 1 (hDDAH1) gene was reported to have beneficial cardiovascular effects in mice. To date, it is unclear whether these effects are related to enhanced meta
Autor:
Daniela Koller, Gerhard Schön, Heike Hansen, Gerd Glaeske, Eike-Christin von Leitner, Karl Wegscheider, Hendrik van den Bussche, Tina Kolonko, Ingmar Schäfer
Publikováno v:
BMC Public Health
BMC Public Health, Vol 11, Iss 1, p 101 (2011)
BMC Public Health, Vol 11, Iss 1, p 101 (2011)
Background Growing interest in multimorbidity is observable in industrialized countries. For Germany, the increasing attention still goes still hand in hand with a small number of studies on multimorbidity. The authors report the first results of a c
Autor:
Karl Wegscheider, Claudia Küver, Hanna Kaduszkiewicz, Hendrik van den Bussche, Eike-Christin von Leitner, Ingmar Schäfer, András Treszl, Benjamin Gedrose
Publikováno v:
BMC Health Services Research, Vol 10, Iss 1, p 351 (2010)
BMC Health Services Research
BMC Health Services Research
Background The nationwide German disease management program (DMP) for type 2 diabetes was introduced in 2003. Meanwhile, results from evaluation studies were published, but possible baseline differences between DMP and usual-care patients have not be
Autor:
Hendrik van den Bussche, Tina Kolonko, Ingmar Schäfer, Daniela Koller, Karl Wegscheider, Heike Hansen, Gerhard Schön, Hanna Kaduszkiewicz, Gerd Glaeske, Eike-Christin von Leitner
Publikováno v:
PLoS ONE
PLoS ONE, Vol 5, Iss 12, p e15941 (2010)
PLoS ONE, Vol 5, Iss 12, p e15941 (2010)
OBJECTIVE: Multimorbidity is a common problem in the elderly that is significantly associated with higher mortality, increased disability and functional decline. Information about interactions of chronic diseases can help to facilitate diagnosis, ame